Japan Approves LimFlow Study

Japan Approves LimFlow Study

Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved LimFlow's Clinical Trial Notification (CTN) for the Japanese cohort of the ongoing PROMISE II pivotal trial of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System. LimFlow SA, is a pioneer in the...

Latest News


Approvals / Clearance

Clinical Studies / Trials